EP Patent

EP3170818B1 — Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

Assigned to Vertex Pharmaceuticals Inc · Expires 2020-02-19 · 6y expired

What this patent protects

Patent listed against Kalydeco.

Drugs covered by this patent

Patent Metadata

Patent number
EP3170818B1
Jurisdiction
EP
Classification
—
Expires
2020-02-19
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.